SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-048673
Filing Date
2024-04-26
Accepted
2024-04-26 08:33:18
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2024_proxy_notice_access.htm DEFA14A 12980
2 GRAPHIC img173965019_0.jpg GRAPHIC 39433
3 GRAPHIC img173965019_1.jpg GRAPHIC 1538129
4 GRAPHIC img173965019_2.jpg GRAPHIC 262026
  Complete submission text file 0000950170-24-048673.txt   2547043
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41551 | Film No.: 24879013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)